Policy & Regulation

The U.S. Department of Commerce has announced a preliminary dumping margin of 0.61% for India's SRF Limited in its latest review of PET film imports, while rescinding the review for several other producers and maintaining the existing 5.71% All-Others cash deposit rate.

• India PET Film Exports
• US Antidumping Review
• Polyester Film Trade
• SRF Limited
• Packaging Materials Market

The U.S. Department of Commerce has announced preliminary dumping margins of up to 70.21% on Chinese xanthan gum in its latest administrative review, with separate rates assigned to Deosen, Fufeng and Jianlong while the existing 154.07% China-wide entity rate remains unchanged.

• Xanthan Gum Anti Dumping
• US Trade Remedies
• China Chemical Exports
• Food Additives Market
• Chemical Trade Policy

The UK Trade Remedies Authority has proposed anti-dumping duties of up to 63.66% on Chinese rutile titanium dioxide, with minimum charges reaching £876 per metric ton, following findings of dumping and an imminent threat of injury to British producers.

• Titanium Dioxide Anti Dumping
• UK Trade Remedies
• China TiO2 Exports
• Global Pigment Market
• Chemical Trade Policy

The U.S. Department of Commerce has preliminarily assigned a 107.57% countervailing subsidy rate to Chinese rubber accelerator CBS imports and imposed retroactive suspension of liquidation following an affirmative critical circumstances determination.

• Rubber Accelerator CBS
• US Countervailing Duties
• China Chemical Exports
• Trade Remedy Investigation
• Rubber Chemicals Market

The U.S. Commerce Department has completed its first expedited sunset reviews of antidumping orders on methionine from France, Japan and Spain, finding potential renewed dumping margins of up to 43.82%, 76.50% and 37.53%, respectively.

• Methionine Market
• Animal Nutrition
• Anti Dumping
• Feed Additives
• US Trade Policy

The U.S. Commerce Department has completed its third expedited sunset review of the antidumping order on certain potassium phosphate salts from China, finding that dumping could recur at weighted-average margins of up to 95.40% if the measure were revoked.

• Potassium Phosphate
• Anti Dumping
• Inorganic Chemicals
• China US Trade
• Trade Remedies

The U.S. Commerce Department has completed its first expedited sunset reviews of antidumping orders on methionine from France, Japan and Spain, finding potential renewed dumping margins of up to 43.82%, 76.50% and 37.53%, respectively.

• Methionine Market
• Animal Nutrition
• Anti Dumping
• Feed Additives
• US Trade Policy

The EU’s annual update to its Prior Informed Consent (PIC) Regulation took effect on October 1, broadening export controls on hazardous chemicals and pesticides. Annex I and Annex V were revised, adding over 30 controlled substances. Annex V now bans exports of UV-328, Dechlorane Plus, and Methoxychlor, subject to certain exemptions. Annex I gained 36 chemicals in Part 1, including DEHP, DBP, trichloroethylene, and pesticides like carbendazim, plus 17 substances in Part 2 requiring stricter cons

• EU
• PIC

New U.S. Section 232 tariffs on imported patented pharmaceuticals and associated pharmaceutical ingredients entered their broader implementation phase on September 29, carrying a general 100% rate while approved onshoring plans, selected trading partners and specialty products receive lower or zero tariffs.

• Section 232
• Pharmaceutical Tariffs
• Active Pharmaceutical Ingredients
• Pharma Supply Chain
• US Trade Policy

The United States and China have reached consensus on more favorable tariff treatment covering around USD 30 billion of non-sensitive goods in each direction, including U.S. cosmetics and medical devices and Chinese consumer products, although detailed tariff rates and product lists have not yet been released.

• US China Trade
• Tariff Reduction
• Chemical Trade
• Medical Devices
• Cosmetics Industry

China released its Pharmaceutical Industry Development Plan for 2026–2030, issued by 10 government departments including MIIT, the NDRC and the NMPA. The plan sets priorities for innovation, supply-chain resilience, digital and AI-driven manufacturing, precision medicine, healthcare access and global cooperation. By 2030, above-scale pharmaceutical manufacturers should exceed RMB 3.5 trillion in annual revenue, with innovative drugs growing over 20% yearly. Targets include at least five products

• five-year development plan
• AI-driven
• pharmaceutical
• Supply chain

India's Drugs Technical Advisory Board has recommended amendments to the New Drugs and Clinical Trials Rules, 2019, to clarify GMP requirements for new drugs and APIs made for clinical trials, BA/BE studies, and non-clinical testing. At its 94th meeting on August 27, 2026, the DTAB proposed changes to Rules 55 and 63, separating clinical-development manufacturing from analytical or non-clinical material. Clinical trial and BA/BE batches would require GMP-compliant facilities under the Drugs Rule

• GMP
• pharma
• api
• Clinical
• drug

France, Italy and Germany plan to jointly ask the European Commission within weeks to open a safeguards investigation into PET resin, epoxy resins and fibreglass and set import quotas — a rarely used trade defence tool that would apply to all suppliers, not just China.

• EU China Trade
• Safeguards Investigation
• PET Resin
• Epoxy Resins
• Fibreglass

U.S. Treasury Secretary Scott Bessent and Chinese Vice Premier He Lifeng opened a new round of high-level economic talks in New York on September 20, covering tariffs, critical minerals, artificial intelligence and possible changes to selected investment restrictions, including in pharmaceuticals.

• US China Trade
• Critical Minerals
• Tariff Policy
• Pharma Investment
• Global Trade

The U.S. Department of Commerce formally imposed antidumping and countervailing duty orders on animal-feed-grade L-lysine from China on September 16, with antidumping cash-deposit rates reaching 139.65% and subsidy rates reaching 82.11%.

• L Lysine
• Antidumping Duty
• Countervailing Duty
• Feed Additives
• China US Trade

The U.S. House passed the Lindsey O. Graham Sanctioning Russia and Iran Act of 2026 by 262–159 on September 16, sending legislation that authorizes tariffs of up to 100% on certain major buyers of Russian oil and gas to the president.

• Russia Sanctions
• Energy Trade
• Tariff Policy
• Oil and Gas
• Global Trade

The UK Competition and Markets Authority has formally opened its Phase 1 review of the proposed AkzoNobel–Axalta merger, a transaction expected to create a global coatings company with approximately USD 25 billion in enterprise value and USD 17 billion in annual revenue.

• AkzoNobel Axalta
• Coatings Industry
• Mergers and Acquisitions
• Antitrust Review
• Chemical Industry

A U.S. federal judge has allowed key PFAS claims brought by Connecticut firefighters against more than 20 defendants, including 3M, DuPont and Honeywell, to move forward, including medical-monitoring relief for some firefighters who have not developed outward symptoms of disease.

• PFAS Litigation
• Chemical Regulation
• 3M
• DuPont
• Firefighter Safety

President Donald Trump has publicly urged Ukraine to stop attacking Russian refining and diesel infrastructure as shrinking fuel exports begin to disrupt global logistics, industrial costs and energy policy.

• Global Diesel Market
• Refining Capacity
• Chemical Logistics
• Energy Security
• Russia Ukraine

Britain’s proposed critical chemicals scheme has entered formal subsidy review, with selected producers potentially receiving support covering up to half of eligible project costs.

• Critical Chemicals
• UK Chemical Industry
• Industrial Subsidies
• Supply Chain Resilience
• Chemical Policy